Evidence map›Paper›PMID 27874003›Full record

ArticleNature communications2016

Nanomechanical electro-optical modulator based on atomic heterostructures.

P A Thomas, O P Marshall, F J Rodriguez, G H Auton, V G Kravets, D Kundys, Y Su, A N Grigorenko

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 12 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

P A ThomasSchool of Physics and Astronomy, University of Manchester, Manchester M13 9PL, UK.
O P MarshallSchool of Physics and Astronomy, University of Manchester, Manchester M13 9PL, UK.
F J RodriguezSchool of Physics and Astronomy, University of Manchester, Manchester M13 9PL, UK.
G H AutonSchool of Computer Science, University of Manchester, Manchester M13 9PL, UK.
V G KravetsSchool of Physics and Astronomy, University of Manchester, Manchester M13 9PL, UK.
D KundysSchool of Physics and Astronomy, University of Manchester, Manchester M13 9PL, UK.
Y SuSchool of Physics and Astronomy, University of Manchester, Manchester M13 9PL, UK.
A N GrigorenkoSchool of Physics and Astronomy, University of Manchester, Manchester M13 9PL, UK.
University of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two-dimensional atomic heterostructures combined with metallic nanostructures allow one to realize strong light-matter interactions. Metallic nanostructures possess plasmonic resonances that can be modulated by graphene gating. In particular, spectrally narrow plasmon resonances potentially allow for very high graphene-enabled modulation depth. However, the modulation depths achieved with this approach have so far been low and the modulation wavelength range limited. Here we demonstrate a device in which a graphene/hexagonal boron nitride heterostructure is suspended over a gold nanostripe array. A gate voltage across these devices alters the location of the two-dimensional crystals, creating strong optical modulation of its reflection spectra at multiple wavelengths: in ultraviolet Fabry-Perot resonances, in visible and near-infrared diffraction-coupled plasmonic resonances and in the mid-infrared range of hexagonal boron nitride's upper Reststrahlen band. Devices can be extremely subwavelength in thickness and exhibit compact and truly broadband modulation of optical signals using heterostructures of two-dimensional materials.

Identifiers

PMID27874003
PMCPMC5121424
OpenAlexW2553182568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.